# EDGAR Filing Document

**Accession Number:** 0001810747
**File Stem:** 0000940400-26-007073
**Filing Date:** 2026-2
**Character Count:** 15595
**Document Hash:** ff33ea5ecb6d2453f80fb3bdfd09c817
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-007073.hdr.sgml**: 20260223

**ACCESSION NUMBER**: 0000940400-26-007073

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260223

**DATE AS OF CHANGE**: 20260223

**PERIOD START**: 20260630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Simplify Exchange Traded Funds
- **CENTRAL INDEX KEY:** 0001810747

**ORGANIZATION NAME:**
- **EIN:** 851887571
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23570
- **FILM NUMBER:** 26664146

**BUSINESS ADDRESS:**
- **STREET 1:** 222 BROADWAY
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10038
- **BUSINESS PHONE:** 646-741-2438

**MAIL ADDRESS:**
- **STREET 1:** 222 BROADWAY
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10038

## Series and Classes Contracts Data

### Simplify Propel Opportunities ETF (Series ID: S000078061)

| Class ID   | Class Name                        | Ticker Symbol   |
|:---|:---|:---|
| C000238807 | Simplify Propel Opportunities ETF | SURI            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Simplify Exchange Traded Funds

- **b. Investment Company Act file number:** 811-23570

- **c. CIK number of Registrant:** 0001810747

- **d. LEI of Registrant:** 549300LDDEMEUCZQEO55

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 10845 Griffith Peak Drive

  - **City:** Las Vegas

  - **State:** NV

  - **Foreign country:** US

  - **Zip / Postal Code:** 89135

  - **Telephone number:** (702) 389-9705

**Item A.2. Information about the Series.**

- **a. Name of Series:** Simplify Propel Opportunities ETF

- **b. EDGAR series identifier (if any):** S000078061

- **c. LEI of Series:** 549300DJ9GVPZFC9VR09

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-06-30

- **b. Date as of which information is reported:** 2025-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $104478786.84

**Total Liabilities:** $29231896.57

**Net Assets:** $75246890.27

**Cash Not Reported:** $17.56

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000238807 | 10.34%               | 5.83%                | -3.50%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-97333.83               | $6904683.01                                |
| Month 2  | $-624747.56              | $5215307.79                                |
| Month 3  | $2143972.04              | $-4942887.10                               |

**Designated Index Information**

- **Index Name:** Self Reference

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                          | Title                         | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| QUOIN PHARMACEUTIC WTS        | QUOIN PHARMACEUTIC WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34895 | NS      | $186862.73    | 0.25%             |  |  |  | No            |                  3 | On Loan: No      |
| WTS - ACHIEVE LIFE SCI        | WTS - ACHIEVE LIFE SCI        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    966667 | NS      | $1904333.99   | 2.53%             |  |  |  | No            |                  3 | On Loan: No      |
| QUOIN PHARMACEUTIC WTS        | QUOIN PHARMACEUTIC WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34895 | NS      | $143680.16    | 0.19%             |  |  |  | No            |                  3 | On Loan: No      |
| Viridian Therapeutics Inc     | Viridian Therapeutics Inc     | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |    103531 | NS      | $3221884.72   | 4.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Abeona Therapeutics Inc       | Abeona Therapeutics Inc       | CUSIP: 00289Y206<br>LEI: 54930002Z8PIJRCB4576 | Long             | EC               | CORP              | US        |    500342 | NS      | $2636802.34   | 3.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Achieve Life Sciences Inc     | Achieve Life Sciences Inc     | CUSIP: 004468500<br>LEI: 549300V82ZKZDTAU0A46 | Long             | EC               | CORP              | US        |   1184512 | NS      | $5887024.64   | 7.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Kalaris Therapeutics Inc      | Kalaris Therapeutics Inc      | CUSIP: 482929106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     20074 | NS      | $169424.56    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| REGENXBIO Inc                 | REGENXBIO Inc                 | CUSIP: 75901B107<br>LEI: 549300EOES47LATSET33 | Long             | EC               | CORP              | US        |     38000 | NS      | $547200.00    | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Phathom Pharmaceuticals Inc   | Phathom Pharmaceuticals Inc   | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    321935 | NS      | $5340901.65   | 7.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Zevra Therapeutics Inc        | Zevra Therapeutics Inc        | CUSIP: 488445206<br>LEI: 254900CU6T74V18Y1W18 | Long             | EC               | CORP              | US        |     37821 | NS      | $338876.16    | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| TREASURY BILL                 | United States Treasury Bill   | CUSIP: 912797TK3<br>LEI: 254900HROIFWPRGM1V77 | Long             | DBT              | UST               | US        |  30000000 | PA      | $29660240.70  | 39.42%            | 2026-04-28      | None          | 0.00%                 | No            |                  1 | On Loan: No      |
| QUOIN PHARMACEUTIC WTS        | QUOIN PHARMACEUTIC WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34895 | NS      | $503531.36    | 0.67%             |  |  |  | No            |                  3 | On Loan: No      |
| JASPER THERAPEUTIC WTS        | JASPER THERAPEUTIC WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    609053 | NS      | $0.61         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| MORGAN STANLEY & CO. LLC      | Morgan Stanley                | CUSIP: 000000000<br>LEI: 9R7GPTSO7KV3UQJZQ078 | Short            | RA               | CORP              | US        | -29059585 | PA      | $-29059585.00 | -38.62%           |  |  |  | No            |                  2 | On Loan: No      |
| Compass Pathways Plc          | Compass Pathways Plc          | CUSIP: 20451W101<br>LEI: 213800N7CUZIC6QSTZ31 | Long             | EC               | CORP              | GB        |    290000 | NS      | $2001000.00   | 2.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Celldex Therapeutics Inc      | Celldex Therapeutics Inc      | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |     85000 | NS      | $2308600.00   | 3.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Plains GP Holdings LP         | Plains GP Holdings LP         | CUSIP: 72651A207<br>LEI: 549300O56BSKRD8FAM12 | Long             | EC               | CORP              | US        |   1272360 | NS      | $24352970.40  | 32.36%            |  |  |  | No            |                  1 | On Loan: No      |
| Eiger BioPharmaceuticals Inc  | Eiger BioPharmaceuticals Inc  | CUSIP: 28249U204<br>LEI: 549300GO4VMIHDKJNU46 | Long             | EC               | CORP              | US        |     90000 | NS      | $900.00       | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Aardvark Therapeutics Inc     | Aardvark Therapeutics Inc     | CUSIP: 002942100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2808 | NS      | $36855.00     | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| TELESAT CANADA/TELESAT L      | Telesat Canada / Telesat LLC  | CUSIP: 87952VAR7<br>LEI: N/A                  | Long             | DBT              | CORP              | CA        |   1000000 | PA      | $799300.00    | 1.06%             | 2026-12-06      | Fixed         | 5.62%                 | No            |                  2 | On Loan: No      |
| Milestone Pharmaceuticals Inc | Milestone Pharmaceuticals Inc | CUSIP: 59935V107<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |   1506405 | NS      | $3042938.10   | 4.04%             |  |  |  | No            |                  1 | On Loan: No      |
| SAB Biotherapeutics Inc       | SAB Biotherapeutics Inc       | CUSIP: 78397T202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    208227 | NS      | $778768.98    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics           | Nektar Therapeutics           | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     28000 | NS      | $1183840.00   | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Delcath Systems Inc           | Delcath Systems Inc           | CUSIP: 24661P807<br>LEI: 549300NVPLITUM6URT02 | Long             | EC               | CORP              | US        |    261126 | NS      | $2637372.60   | 3.50%             |  |  |  | No            |                  1 | On Loan: No      |
| MILESTONE PHARMACE WTS        | MILESTONE PHARMACE WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1842974 | NS      | $267231.23    | 0.36%             |  |  |  | No            |                  3 | On Loan: No      |
| CHINOOK THERAPEUTICS INC CVR  | CHINOOK THERAPEUTICS INC CVR  | CUSIP: 169CVR016<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     25000 | NS      | $2500.00      | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| DREYFUS TRSY OBLIG CASH M     | DREYFUS TRSY OBLIG CASH M     | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |   8146920 | NS      | $8146920.23   | 10.83%            |  |  |  | No            |                  1 | On Loan: No      |
| Oculis Holding AG             | Oculis Holding AG             | CUSIP: 000000000<br>LEI: 5067005370C2KK324336 | Long             | EC               | CORP              | CH        |     98765 | NS      | $1972337.05   | 2.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Inventiva SACA                | Inventiva SACA                | CUSIP: 46124U107<br>LEI: 969500I9Y690B3FZW590 | Long             | EC               | CORP              | FR        |    337662 | NS      | $1570128.30   | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| MILESTONE PHARMACE WTS        | MILESTONE PHARMACE WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1842974 | NS      | $958346.48    | 1.27%             |  |  |  | No            |                  3 | On Loan: No      |
| Athira Pharma Inc             | Athira Pharma Inc             | CUSIP: 04746L203<br>LEI: 529900CSS4S4X8VY5C81 | Long             | EC               | CORP              | US        |    149279 | NS      | $1130042.03   | 1.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Applied Therapeutics Inc      | Applied Therapeutics Inc      | CUSIP: 03828A101<br>LEI: 549300KL3IJPHZM2GR04 | Long             | EC               | CORP              | US        |    555467 | NS      | $55546.70     | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Kyverna Therapeutics Inc      | Kyverna Therapeutics Inc      | CUSIP: 501976104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    192339 | NS      | $1807986.60   | 2.40%             |  |  |  | No            |                  1 | On Loan: No      |
| WTS - TENAYA THERAPEUTICS     | WTS - TENAYA THERAPEUTICS     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    560000 | NS      | $0.56         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| QUOIN PHARMACEUTIC WTS        | QUOIN PHARMACEUTIC WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34895 | NS      | $71709.23     | 0.10%             |  |  |  | No            |                  3 | On Loan: No      |
| LENZ Therapeutics Inc         | LENZ Therapeutics Inc         | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     17481 | NS      | $279696.00    | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc        | Akero Therapeutics Inc        | CUSIP: 00973Y108<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |    145609 | NS      | $426634.37    | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| QUOIN PHARMACEUTIC WTS        | QUOIN PHARMACEUTIC WTS        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     34895 | NS      | $71709.23     | 0.10%             |  |  |  | No            |                  3 | On Loan: No      |

### Signature

**Date Signed:** 2026-02-21

**Name of Applicant:** Simplify Exchange Traded Funds

**Signature:** Paul Kim

**Name of Signer:** Paul Kim

**Title:** Trustee & President